Moomoo AI 已提取核心信息
Kynam Capital Management, LP, along with its general partner Kynam Capital Management GP, LLC, and Yue Tang, have filed a Schedule 13G with the United States Securities and Exchange Commission on January 10, 2024, indicating a significant ownership stake in Burning Rock Biotech Limited. The filing, dated December 31, 2023, reveals that the entities collectively hold 8,694,426 Class A Ordinary Shares, representing 10.19% of the class. The shares are reported to be beneficially owned with both sole and shared voting and dispositive power. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of influencing control of the company. Burning Rock Biotech Limited, headquartered in Guangzhou, China, is the issuer of the securities in question. Kynam Capital Management and its associated entities are organized under the laws of Delaware, with Yue Tang, a U.S. citizen, serving as the Managing Member.
Kynam Capital Management, LP, along with its general partner Kynam Capital Management GP, LLC, and Yue Tang, have filed a Schedule 13G with the United States Securities and Exchange Commission on January 10, 2024, indicating a significant ownership stake in Burning Rock Biotech Limited. The filing, dated December 31, 2023, reveals that the entities collectively hold 8,694,426 Class A Ordinary Shares, representing 10.19% of the class. The shares are reported to be beneficially owned with both sole and shared voting and dispositive power. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of influencing control of the company. Burning Rock Biotech Limited, headquartered in Guangzhou, China, is the issuer of the securities in question. Kynam Capital Management and its associated entities are organized under the laws of Delaware, with Yue Tang, a U.S. citizen, serving as the Managing Member.
Kynam Capital Management, LP及其普通合伙人Kynam Capital Management GP, LLC和Yue Tang已于2024年1月10日向美国证券交易委员会提交了附表13G，表示拥有Burning Rock Biotech Limited的大量所有权。这份日期为2023年12月31日的文件显示，这些实体共持有8,694,426股A类普通股，占该类别的10.19％。据报道，这些股票是实益拥有的，具有唯一和共享的投票权和处置权。文件显示，这些股份是在正常业务过程中收购的，不是为了影响公司的控制权。总部位于中国广州的燃石生物技术有限公司是有关证券的发行人。Kynam Capital Management及其关联实体根据特拉华州法律组建，管理成员为美国公民 Yue Tang。
Kynam Capital Management, LP及其普通合伙人Kynam Capital Management GP, LLC和Yue Tang已于2024年1月10日向美国证券交易委员会提交了附表13G，表示拥有Burning Rock Biotech Limited的大量所有权。这份日期为2023年12月31日的文件显示，这些实体共持有8,694,426股A类普通股，占该类别的10.19％。据报道，这些股票是实益拥有的，具有唯一和共享的投票权和处置权。文件显示，这些股份是在正常业务过程中收购的，不是为了影响公司的控制权。总部位于中国广州的燃石生物技术有限公司是有关证券的发行人。Kynam Capital Management及其关联实体根据特拉华州法律组建，管理成员为美国公民 Yue Tang。
有用
没用